Moloney Securities Asset Management LLC lifted its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 53.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,732 shares of the company's stock after purchasing an additional 14,245 shares during the quarter. Moloney Securities Asset Management LLC's holdings in Roche were worth $1,672,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in RHHBY. HighPoint Advisor Group LLC raised its stake in shares of Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after purchasing an additional 304 shares during the last quarter. Fulton Bank N.A. increased its holdings in Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after buying an additional 314 shares in the last quarter. GAMMA Investing LLC raised its position in Roche by 59.5% in the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after buying an additional 4,794 shares during the last quarter. Confluence Investment Management LLC raised its position in Roche by 3.6% in the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after buying an additional 510 shares during the last quarter. Finally, Minot DeBlois Advisors LLC purchased a new position in Roche in the 4th quarter worth about $752,000.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Hsbc Global Res cut Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC cut Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Roche presently has a consensus rating of "Moderate Buy".
Read Our Latest Stock Report on RHHBY
Roche Trading Up 1.9%
Shares of OTCMKTS:RHHBY traded up $0.78 during trading on Wednesday, reaching $40.87. The stock had a trading volume of 1,010,783 shares, compared to its average volume of 2,513,252. The company has a quick ratio of 1.20, a current ratio of 1.48 and a debt-to-equity ratio of 0.85. The firm's 50-day simple moving average is $40.09 and its 200 day simple moving average is $39.61. Roche Holding AG has a one year low of $34.10 and a one year high of $44.31.
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Stories

Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.